Peregrine Pharma New (PPHM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PPHM | AMGN | VRTX | REGN | GSK |
| Company | Peregrine Pharma New | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 4.24 | 297.61 | 477.73 | 1,024.30 | 40.82 |
| High | 4.25 | 299.74 | 483.53 | 1,042.66 | 40.88 |
| Low | 4.18 | 295.90 | 477.73 | 1,017.96 | 40.48 |
| Last | 4.22 | 298.62 | 480.73 | 1,036.52 | 40.65 |
| Change | +0.03 | +0.12 | +1.70 | +9.97 | -0.46 |
| % Change | +0.72% | +0.04% | +0.35% | +0.97% | -1.12% |
| Volume | 93,000 | 1,713,600 | 641,700 | 353,900 | 2,235,300 |
| 20-Day Average Volume | 254,905 | 2,175,800 | 1,196,295 | 382,520 | 3,991,900 |
| Previous Close | 4.19 | 298.50 | 479.03 | 1,026.55 | 41.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.24 | 305.18 | 463.59 | 994.90 | 42.98 |
| 20-Day Raw Stochastic | 27.59% | 15.54% | 88.80% | 93.20% | 3.29% |
| 20-Day Relative Strength | 48.73% | 49.90% | 69.81% | 69.37% | 39.17% |
| Weighted Alpha | +32.90 | +26.02 | +43.64 | +35.89 | +13.64 |
| Today's Opinion | N/A | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | N/A | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | N/A | 72% Buy | 56% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.76% since 12/29/17 | -2.10% since 06/07/24 | -0.48% since 06/07/24 | +3.35% since 06/07/24 | -1.36% since 06/07/24 |
| Low | 3.88 on 01/02/18 | 295.30 on 06/13/24 | 472.61 on 06/13/24 | 992.22 on 06/10/24 | 40.47 on 06/14/24 |
| High | 4.25 on 01/05/18 | 305.53 on 06/10/24 | 485.40 on 06/10/24 | 1,042.66 on 06/14/24 | 41.51 on 06/10/24 |
| 1-Month | |||||
| %Chg | -19.77% since 12/05/17 | -4.11% since 05/14/24 | +12.17% since 05/14/24 | +5.27% since 05/14/24 | -10.97% since 05/14/24 |
| Low | 3.74 on 12/21/17 | 295.30 on 06/13/24 | 428.62 on 05/15/24 | 952.30 on 05/30/24 | 40.47 on 06/14/24 |
| High | 5.48 on 12/11/17 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +23.39% since 10/05/17 | +9.97% since 03/14/24 | +17.60% since 03/14/24 | +8.08% since 03/14/24 | -5.64% since 03/14/24 |
| Low | 3.28 on 10/09/17 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 5.48 on 12/11/17 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -4.31% since 07/05/17 | +8.07% since 12/14/23 | +18.23% since 12/14/23 | +18.32% since 12/14/23 | +9.92% since 12/14/23 |
| Low | 2.85 on 09/08/17 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 838.46 on 12/21/23 | 35.87 on 12/15/23 |
| High | 5.78 on 07/14/17 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 190,786 | 160,190,224 | 124,053,832 | 114,209,984 | 84,244,688 |
| Shares Outstanding, K | 45,210 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 57,630,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -28,160,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 12,780,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -12,620,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 2.74 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 09/11/17 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 12/11/17 | 08/01/24 | 08/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.02 | 31.81 | 27.66 | 10.18 |